文献速递瓣膜病与结构性心脏病

社区老年人群瓣膜性心脏病分期:ARIC研究

Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
PubMed 文献 · Circulation · 2022-12-16

ARIC前瞻性队列研究对6118名平均76岁老年人进行协议超声心动图检查,按ACC/AHA指南定义瓣膜性心脏病分期。发现39%为A期、17%为B期、1.1%为C/D期,且分期与全因死亡、心衰、房颤和冠心病风险呈梯度相关,约6年后C/D期患病率从1%升至7%。

要点

  • 社区老年人中亚临床瓣膜病常见:A期39%、B期17%。
  • 瓣膜病分期与死亡、心衰、房颤和冠心病风险呈梯度相关。
  • 约6年内C/D期患病率从1%升至7%,进展显著。

核心结论

  • 亚临床瓣膜病在老年人中常见,A期占39%、B期占17%,且独立关联新发心血管事件风险。
  • 瓣膜病分期在晚年约6年内进展,C/D期患病率从1%升至7%,凸显干预延缓进展的公共卫生重要性。

研究设计与样本

  • ARIC前瞻性社区队列研究,第5次访视(2011-2013)和第7次访视(2018-2019)进行协议超声心动图。
  • 共6118名参与者,平均年龄76±5岁,42%男性,22%自报黑人。
  • 按ACC/AHA指南定义主动脉瓣狭窄、主动脉瓣反流、二尖瓣狭窄和二尖瓣反流的瓣膜病分期。
  • 采用Cox比例风险模型评估瓣膜病分期与新发事件的关联,调整年龄、性别、种族、高血压、糖尿病等因素。
  • 使用逆概率衰减权重估计约6年间瓣膜病分期患病率的纵向变化。

主要发现

  • 第5次访视时A期瓣膜病占39%,B期占17%,C/D期占1.1%,0.7%曾接受瓣膜置换或修复。
  • A、B、C/D期与全因死亡、新发心衰、新发房颤和新发冠心病风险呈梯度关联,但与卒中无关联。
  • 各瓣膜病变单独分期也观察到类似关联。
  • 第5至7次访视间隔6.6年(IQR 6.1-7.0),平均年龄81±4岁,无瓣膜病比例从43%降至24%,C/D期从1%升至7%。

关键数值与推荐

  • ACC/AHA瓣膜病分期:A期为风险期,B期为进展期,C/D期为重度瓣膜病。
  • A期患病率39%,B期17%,C/D期1.1%。
  • 6.6年间C/D期患病率从1%增至7%。

临床怎么用

  • 社区老年人群中应关注亚临床瓣膜病,A期和B期患者需监测进展。
  • 瓣膜病分期可帮助识别新发心衰、房颤、冠心病和死亡高风险人群。
  • 需探索干预措施以延缓瓣膜病从A/B期向C/D期进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data exist on American College of Cardiology/American Heart Association valvular heart disease (VHD) stage prevalence, progression, and association with incident cardiovascular diseases in late life. METHODS: Participants in the ARIC study (Atherosclerosis Risk in Communities), a prospective community-based cohort study, underwent protocol echocardiography at ARIC visits 5 (2011-2013) and 7 (2018-2019), and their aortic stenosis, aortic regurgitation, mitral stenosis, and mitral regurgitation stage were defined according to American College of Cardiology/American Heart Association guidelines. The overall VHD stage prevalence at visit 5 was measured. The associations between VHD stages and incident adjudicated death, heart failure, coronary heart disease, stroke, and atrial fibrillation were assessed with Cox proportional hazard models adjusted for age, sex, race, hypertension, diabetes, prior myocardial infarction, heart failure, body mass index, study center, systolic blood pressure, estimated glomerular filtration rate, and low-density lipoprotein at visit 5. Longitudinal changes in VHD stage prevalence over ≈6 years were estimated with inverse probability of attrition weights to account for participant attrition. RESULTS: Among 6118 ARIC participants, the mean±SD age was 76±5 years, 42% were male, and 22% reported Black race. Stage A VHD was present in 39%, stage B in 17%, and stage C/D in 1.1%;, 0.7% had previously undergone valve replacement or repair. A graded association was observed between stage A, B, and C/D VHD and risk of all-cause mortality, incident heart failure, incident atrial fibrillation, and incident coronary heart disease, but not incident stroke. Similar findings were observed for stages of each valvular lesion individually. During the 6.6 years (interquartile range, 6.1-7.0 years) between visits 5 and 7 (mean age, 81±4 years), the prevalence of freedom from VHD stage decreased from 43% to 24%, whereas the prevalence of stage C/D VHD increased from 1% to 7%. CONCLUSIONS: Subclinical VHD is common in older adults, with 39% at risk (stage A) and 17% with progressive VHD (stage B), and is independently associated with risk of incident cardiovascular events. VHD stages progress over 6 years in late life, with a several-fold increase in prevalence of severe VHD (stage C/D), highlighting the public health importance of interventions to mitigate VHD progression.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Shelbaya K, Claggett B, Dorbala P, et al. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study. Circulation. 2022. PMID: 36524478. doi:10.1161/CIRCULATIONAHA.122.061396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。